Drug
Amg 691
Amg 691: highest development phase Phase 1, developed by Amgen. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| AMG 691 NCT06637371 | Phase 1 | Asthma |
| AMG 691 NCT07745907 | Phase 1 | Healthy Participants |
Latest
No recent events.
Follow Amg 691 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.